Cargando…
CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas
B-cell receptor (BCR) signaling pathway components represent promising treatment targets in multiple B-cell malignancies including diffuse large B-cell lymphoma (DLBCL). In in vitro and in vivo model systems, a subset of DLBCLs depend upon BCR survival signals and respond to proximal BCR/phosphoinos...
Autores principales: | Chen, Linfeng, Ouyang, Jing, Wienand, Kirsty, Bojarczuk, Kamil, Hao, Yansheng, Chapuy, Bjoern, Neuberg, Donna, Juszczynski, Przemyslaw, Lawton, Lee N., Rodig, Scott J., Monti, Stefano, Shipp, Margaret A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193488/ https://www.ncbi.nlm.nih.gov/pubmed/31471373 http://dx.doi.org/10.3324/haematol.2019.216218 |
Ejemplares similares
-
Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
por: Kluk, Michael J., et al.
Publicado: (2012) -
Molecular classification of aggressive B-cell lymphoma
por: Bojarczuk, Kamil, et al.
Publicado: (2019) -
T028: Single-cell RNA sequencing reveals the interplay between circulating CD4 T cells, B cells and cancer-associated monocytes in classic Hodgkin lymphoma treated with PD-1 blockade
por: Paczkowska, Julia, et al.
Publicado: (2022) -
Isotype Specific Assembly of B Cell Antigen Receptors and Synergism With Chemokine Receptor CXCR4
por: Maity, Palash C., et al.
Publicado: (2018) -
Biomarkers for immune checkpoint blockers
por: Wienand, Kirsty, et al.
Publicado: (2018)